These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7047054

  • 21. [Current clinical results of antiplatelet medication].
    Ordinas A.
    Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract] [Full Text] [Related]

  • 22. Antiplatelet therapy.
    Turpie AG.
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract] [Full Text] [Related]

  • 23. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
    Mehta J.
    JAMA; 1983 May 27; 249(20):2818-23. PubMed ID: 6341645
    [No Abstract] [Full Text] [Related]

  • 24. [Hypercoagulability and cerebral infarction].
    Matsuda T.
    No To Shinkei; 1986 Apr 27; 38(4):317-27. PubMed ID: 3013261
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF, Packham MA, Kinlough-Rathbone RL.
    Adv Exp Med Biol; 1977 Apr 27; 82():94-105. PubMed ID: 920448
    [No Abstract] [Full Text] [Related]

  • 28. Platelet-inhibitor drugs' role in coronary artery disease.
    Fuster V, Adams PC, Badimon JJ, Chesebro JH.
    Prog Cardiovasc Dis; 1987 Apr 27; 29(5):325-46. PubMed ID: 3547499
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antiplatelet agents: their role in the prevention of sudden death.
    Hirsh J.
    Ann N Y Acad Sci; 1982 Apr 27; 382():289-304. PubMed ID: 7044244
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG.
    Prog Clin Biol Res; 1982 Apr 27; 89():31-62. PubMed ID: 7051035
    [Abstract] [Full Text] [Related]

  • 35. [Evaluation of antithrombin III activity in ischemic cardiopathy: changes due to treatment with platelet anti-aggregants].
    Avellone G, Mandalà V, Novo S, Davì G, Pinto A, Riolo FP.
    Boll Soc Ital Cardiol; 1979 Apr 27; 24(11):1229-33. PubMed ID: 261907
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
    Weiss HJ.
    Circulation; 1980 Dec 27; 62(6 Pt 2):V41-3. PubMed ID: 7002351
    [Abstract] [Full Text] [Related]

  • 39. [Interrelationships between the hemostatic system and the prostaglandin system in the pathogenesis of ischemic cardiopathy].
    Neri Serneri GG, Masotti G, Gensini GF, Abbate R, Poggesi L.
    G Ital Cardiol; 1981 Dec 27; 11(10):1500-13. PubMed ID: 7042438
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.